Cargando…

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies

Heterologous prime-boost strategies are known to substantially increase immune responses in viral vectored vaccines. Here we report on safety and immunogenicity of the poxvirus Modified Vaccinia Ankara (MVA) vectored vaccine expressing four Mycobacterium avium subspecies paratuberculosis antigens as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Folegatti, Pedro M., Flaxman, Amy, Jenkin, Daniel, Makinson, Rebecca, Kingham-Page, Lucy, Bellamy, Duncan, Ramos Lopez, Fernando, Sheridan, Jonathan, Poulton, Ian, Aboagye, Jeremy, Tran, Nguyen, Mitton, Celia, Roberts, Rachel, Lawrie, Alison M., Hill, Adrian V. S., Ewer, Katie J., Gilbert, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000717/ https://www.ncbi.nlm.nih.gov/pubmed/33809415 http://dx.doi.org/10.3390/vaccines9030262

Ejemplares similares

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
por: Folegatti, Pedro M., et al.
Publicado: (2019)

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
por: Folegatti, Pedro M., et al.
Publicado: (2019)

Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial
por: Jenkin, Daniel, et al.
Publicado: (2022)

A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial
por: Folegatti, Pedro M., et al.
Publicado: (2021)

Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial
por: Madhavan, Meera, et al.
Publicado: (2022)

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
por: Folegatti, Pedro M, et al.
Publicado: (2020)

CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination
por: Sharpe, Hannah R., et al.
Publicado: (2022)

Deep Immune Phenotyping and Single-Cell Transcriptomics Allow Identification of Circulating TRM-Like Cells Which Correlate With Liver-Stage Immunity and Vaccine-Induced Protection From Malaria
por: Noé, Andrés, et al.
Publicado: (2022)

Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
por: Coughlan, L., et al.
Publicado: (2018)

Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley Fever in adults: an open-label, non-randomised, first-in-human phase 1 clinical trial
por: Jenkin, Daniel, et al.
Publicado: (2023)

Optical mapping of the Mycobacterium avium subspecies paratuberculosis genome
por: Wu, Chia-wei, et al.
Publicado: (2009)

Killing of Mycobacterium avium subspecies paratuberculosis within macrophages
por: Bannantine, John P, et al.
Publicado: (2002)

Diagnostic Sequences That Distinguish M. avium Subspecies Strains
por: Bannantine, John P., et al.
Publicado: (2021)

Immunogenicity of poxvirus-based vaccines against Nipah virus
por: Medina-Magües, Emily S., et al.
Publicado: (2023)

Efficacy and Safety of a Modified Vaccinia Ankara-NP+M1 Vaccine Combined with QIV in People Aged 65 and Older: A Randomised Controlled Clinical Trial (INVICTUS)
por: Butler, Chris, et al.
Publicado: (2021)

On the Action of Methotrexate and 6-Mercaptopurine on M. avium Subspecies paratuberculosis
por: Greenstein, Robert J., et al.
Publicado: (2007)

Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenario
por: Hermon-Taylor, John
Publicado: (2009)

Search for Mycobacterium avium Subspecies paratuberculosis Antigens for the Diagnosis of Paratuberculosis
por: Mon, María Laura, et al.
Publicado: (2012)

Genome analysis of Mycobacterium avium subspecies hominissuis strain 109
por: Matern, William M., et al.
Publicado: (2018)

Comparative Genomics of Mycobacterium avium Subspecies Paratuberculosis Sheep Strains
por: Mizzi, Rachel, et al.
Publicado: (2021)

Mycobacterium avium Subspecies paratuberculosis in Asymptomatic Zoo Herbivores in Poland
por: Bruczyńska, Małgorzata, et al.
Publicado: (2023)

Protective RNA nanovaccines against Mycobacterium avium subspecies hominissuis
por: Touray, Bubacarr J.B., et al.
Publicado: (2023)

Mycobacterium avium subspecies paratuberculosis is not associated with Type-2 Diabetes Mellitus
por: Rosu, Valentina, et al.
Publicado: (2008)

Where Are All the Mycobacterium avium Subspecies paratuberculosis in Patients with Crohn's Disease?
por: Pierce, Ellen S.
Publicado: (2009)

Phylogenomic exploration of the relationships between strains of Mycobacterium avium subspecies paratuberculosis
por: Bryant, Josephine M., et al.
Publicado: (2016)

Mycobacterium avium subspecies hominissuis in Crohn’s disease: a case report
por: Zhang, Peilin, et al.
Publicado: (2017)

Molecular and Serological Footprints of Mycobacterium avium Subspecies Infections in Zoo Animals
por: Roller, Marco, et al.
Publicado: (2020)

Sero-surveillance of Mycobacterium avium subspecies paratuberculosis infection in ruminants in Medina
por: Shabana, Iman Ibrahim, et al.
Publicado: (2019)

Electrochemical Detection of Serum Antibodies Against Mycobacterium avium Subspecies paratuberculosis
por: Hatate, Kaoru, et al.
Publicado: (2021)

Neglected Facts on Mycobacterium Avium Subspecies Paratuberculosis and Type 1 Diabetes
por: Ozana, Veronika, et al.
Publicado: (2022)

Mycobacterium avium subspecies paratuberculosis (MAP) and Crohn’s disease: the debate continues
por: Mintz, Michael J., et al.
Publicado: (2023)

Corrigendum to “Heterologous Two-dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-lasting Cellular Immunity to Influenza Virus A in Healthy Adults” [EBioMedicine 29 (2018) 146–154]
por: Coughlan, L., et al.
Publicado: (2018)

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
por: Folegatti, Pedro M, et al.
Publicado: (2020)

Immunity, safety and protection of an Adenovirus 5 prime - Modified Vaccinia virus Ankara boost subunit vaccine against Mycobacterium avium subspecies paratuberculosis infection in calves
por: Bull, Tim J, et al.
Publicado: (2014)

Freeze-Drying Formulations Increased the Adenovirus and Poxvirus Vaccine Storage Times and Antigen Stabilities
por: Chen, Ye, et al.
Publicado: (2020)

On the Action of Cyclosporine A, Rapamycin and Tacrolimus on M. avium Including Subspecies paratuberculosis
por: Greenstein, Robert J., et al.
Publicado: (2008)

Ulcerative colitis and Crohn's disease: is Mycobacterium avium subspecies paratuberculosis the common villain?
por: Pierce, Ellen S
Publicado: (2010)

Exploring the Zoonotic Potential of Mycobacterium avium Subspecies paratuberculosis through Comparative Genomics
por: Wynne, James W., et al.
Publicado: (2011)

The Thioamides Methimazole and Thiourea Inhibit Growth of M. avium Subspecies paratuberculosis in Culture
por: Greenstein, Robert J., et al.
Publicado: (2010)

Intestinal infection following aerosol challenge of calves with Mycobacterium avium subspecies paratuberculosis
por: Eisenberg, Susanne WF, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_pijl5r9h3o82i9vvrko3lgrp6g